Technical analysis of Moody's Corporation (MCO): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Moody's Corporation operates as a global leader in risk assessment, divided into two main segments: Moody's Investors Service and Moody's Analytics. Moody's Investors Service is dedicated to issuing credit ratings and providing detailed assessments for a diverse range of debt obligations and the entities that issue them. This encompasses corporate, financial institution, governmental, and structured finance securities across approximately 140 nations.
Price Performance
| 1 month | +14.65% |
| 3 months | +4.55% |
| Year-to-date | -0.95% |
| 1 year | +4.13% |
| 3 years | +52.68% |
| 5 years | +30.07% |
| 10 years | +418.41% |
52-Week Range
| 52-week High | $546.88 |
| 52-week Low | $402.28 |
| Avg Volume (90d) | 845K |
Technical Indicators
| SMA 50 | $477.38 |
| SMA 200 | $466.63 |
| Beta | 1.45 |
| 30-day Volatility (annualised) | 24.3% |
| Price vs SMA 50 | +6.0% |
| Price vs SMA 200 | +8.4% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $510.85 | |
| 2026-01 | $515.56 | +0.9% |
| 2026-02 | $477.59 | -7.4% |
| 2026-03 | $436.25 | -8.7% |
| 2026-04 | $461.85 | +5.9% |
| 2026-05 | $453.25 | -1.9% |
| 2026-06 | $452.92 | -0.1% |
| 2026-07 | $478.38 | +5.6% |
| 2026-08 | $504.64 | +5.5% |
| 2026-09 | $454.13 | -10.0% |
| 2026-10 | $493.97 | +8.8% |
| 2026-11 | $506.02 | +2.4% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-02-17 | $3.62 | $1.93B |
| 2026-10-21 | $4.25 | $2.08B |
| 2026-07-22 | $4.26 | $2.09B |
| 2026-04-22 | $4.22 | $2.07B |
| 2026-02-18 | $3.43 | $1.86B |
| 2025-10-22 | $3.70 | $1.96B |
| 2025-07-23 | $3.39 | $1.85B |
Price
| Price | $506.02 (closing price, November 2, 2026) |
| Market Cap | $87.3B |
| Exchange | NYSE |
| Country | US |
Valuation Ratios
| P/E Ratio | 30.85 |
| Price / Book | 26.76 |
| Dividend Yield | 0.80% |
Financial Health
| Debt / Equity | 2.29 |
| Current Ratio | 1.29 |
| Piotroski F-Score | 8 |
| Altman Z-Score | 7.68 |